Vimarsana
Biggest News Aggregation in the World

Page 2 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Sclerosis Today - Breaking & Trending Today

Scleroderma causes, symptoms: Use saline water, wear gloves and socks to avoid this autoimmune disease - Vimarsana News

Scleroderma causes, symptoms: Use saline water, wear gloves and socks to avoid this autoimmune disease

Scleroderma is a complex autoimmune disorder that affects connective tissues, characterized by skin tightening and internal organ fibrosis. You can manage its symptoms by staying warm or by using saline soaks or warm water.

More than 140 healthcare professionals gather at 3rd ILD summit - Vimarsana News

More than 140 healthcare professionals gather at 3rd ILD summit

Over 140 healthcare professionals from the Middle East and Africa gathered for the third edition of the Interstitial Lung Disease (ILD) Summit to discuss the latest developments in the treatment and management of respiratory conditions.

Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug - Vimarsana News

Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug

Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.

NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE - Vimarsana News

NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agents and Chemotherapy1 detailing the...

Nintedanib Dose Reductions in IPF May Do No Harm - Vimarsana News

Nintedanib Dose Reductions in IPF May Do No Harm

Patients with idiopathic pulmonary fibrosis who required dose reductions had similar all-cause mortality and death rates vs patients on the full dose.